BMP4 and tuberculosis: More specific and more potent inhibitors of activin A signaling, such as A83-01 (Tojo et al. 2005; Garamszegi and Garamszegi 2011), may provide improved tools for directing hESC to TB (see ‘‘Is TB derived from BMP4-treated hESC and iPSC a mesoderm derivative?”).